CAD, ELECTROLYTE IMBALANCES, IMPAIRED GAS EXCHANGE, DRUG TOXICITY CAUSES OF DYSRHYTHMIAS DIGOXIN SHOULD BE HELD 48 HOURS BEFORE CARDIOVERSION DUE TO RISK OF VENTRICULAR FIBRILLATION PULSELESS VENTRICULAR TACHYCARDIA & VENTRICULAR FIBRILLATION TWO RHYTHMS THAT REQUIRE DEFIBRILLATION PROCAINAMIDE, SOTALOL, AMIODARONE RECOMMENDED MEDICATIONS TO TREAT VENTRICULAR TACHYCARDIA WITH A PULSE EPINEPHRINE FIRST LINE TREATMENT FOR PULSELESS TACHYCARDIA AND VENTRICULAR FIBRILLATION LEADS II, III, AND AVF INFERIOR MYOCARDIAL INFARCTION PULSELESS VENTRICULAR TACHYCARDIA OFTEN THE RHYTHM TH AT PRECEDES VENTRICULAR FIBRILLATION SA NODE NATURAL PACEMAKER OF THE HEART P WAVE REPRESENTS ATRIAL DEPOLARIZATION VAGAL MANEUVERS, ADENOSINE, BETA BLOCKERS, CALCIUM CHANNEL BLOCKERS RECOMMENDED TREATMENT FOR SUPRAVENTRICULAR TACHYCARDIA (SVT) LEADS V3 AND V4 ANTERIOR MYOCARDIAL INFARCTION SYNCHRONIZED CARDIOVERSION TREATMENT RECOMMENDED FOR ANY FAST RHYTHM WITH SIGNS OF SHOCK OR POOR PERFUSION PERMANENT PACEMAKER RECOMMENDED TREATMENT FOR THIRD DEGREE HEART BLOCK AUTOMATICITY, CONDUCTION, CONTRACTILITY, EXCITABILITY PROPERTIES OF CARDIAC CELLS ATROPINE 1ST LINE TREATMENT FOR SYMPTOMATIC BRADYCARDIA ST SEGMENT EXAMINE FOR ELEVATION OR DEPRESSION TO EVALUATE FOR ISCHEMIA, INJURY, OR INFARCTION CLOTTING EVENTS & HEART FAILURE TWO MAIN COMPLICATIONS OF ATRIAL FIBRILLATION U WAVE ITS PRESENCE OFTEN INDICATES AN ELECTROLYTE IMBALANCE, PARTICULARLY HYPOKALEMIA 0.12 - .20 SECONDS NORMAL PR INTERVAL TIME AMIODARONE & LIDOCAINE SECOND-LINE TREATMENT FOR PULSELESS VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION 4-8 LITERS PER MINUTE WHAT IS NORMAL CARDIAC OUTPUT MAGNESIUM RECOMMENDED TREATMENT FOR TORSADES DE POINTES DECREASED CARDIAC OUTPUT, INEFFECTIVE TISSUE PERFUSION TWO MAIN NURSING DIAGNOSES RELATED TO DYSRHYTHMIAS EPINEPHRINE, DOPAMINE, PACING SECOND-LINE TREATMENT FOR SYMPTOMATIC BRADYCARDIA CAD, ELECTROLYTE IMBALANCES, IMPAIRED GAS EXCHANGE, DRUG TOXICITY CAUSES OF DYSRHYTHMIAS DIGOXIN SHOULD BE HELD 48 HOURS BEFORE CARDIOVERSION DUE TO RISK OF VENTRICULAR FIBRILLATION PULSELESS VENTRICULAR TACHYCARDIA & VENTRICULAR FIBRILLATION TWO RHYTHMS THAT REQUIRE DEFIBRILLATION PROCAINAMIDE, SOTALOL, AMIODARONE RECOMMENDED MEDICATIONS TO TREAT VENTRICULAR TACHYCARDIA WITH A PULSE EPINEPHRINE FIRST LINE TREATMENT FOR PULSELESS TACHYCARDIA AND VENTRICULAR FIBRILLATION LEADS II, III, AND AVF INFERIOR MYOCARDIAL INFARCTION PULSELESS VENTRICULAR TACHYCARDIA OFTEN THE RHYTHM TH AT PRECEDES VENTRICULAR FIBRILLATION SA NODE NATURAL PACEMAKER OF THE HEART P WAVE REPRESENTS ATRIAL DEPOLARIZATION VAGAL MANEUVERS, ADENOSINE, BETA BLOCKERS, CALCIUM CHANNEL BLOCKERS RECOMMENDED TREATMENT FOR SUPRAVENTRICULAR TACHYCARDIA (SVT) LEADS V3 AND V4 ANTERIOR MYOCARDIAL INFARCTION SYNCHRONIZED CARDIOVERSION TREATMENT RECOMMENDED FOR ANY FAST RHYTHM WITH SIGNS OF SHOCK OR POOR PERFUSION PERMANENT PACEMAKER RECOMMENDED TREATMENT FOR THIRD DEGREE HEART BLOCK AUTOMATICITY, CONDUCTION, CONTRACTILITY, EXCITABILITY PROPERTIES OF CARDIAC CELLS ATROPINE 1ST LINE TREATMENT FOR SYMPTOMATIC BRADYCARDIA ST SEGMENT EXAMINE FOR ELEVATION OR DEPRESSION TO EVALUATE FOR ISCHEMIA, INJURY, OR INFARCTION CLOTTING EVENTS & HEART FAILURE TWO MAIN COMPLICATIONS OF ATRIAL FIBRILLATION U WAVE ITS PRESENCE OFTEN INDICATES AN ELECTROLYTE IMBALANCE, PARTICULARLY HYPOKALEMIA 0.12 - .20 SECONDS NORMAL PR INTERVAL TIME AMIODARONE & LIDOCAINE SECOND-LINE TREATMENT FOR PULSELESS VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION 4-8 LITERS PER MINUTE WHAT IS NORMAL CARDIAC OUTPUT MAGNESIUM RECOMMENDED TREATMENT FOR TORSADES DE POINTES DECREASED CARDIAC OUTPUT, INEFFECTIVE TISSUE PERFUSION TWO MAIN NURSING DIAGNOSES RELATED TO DYSRHYTHMIAS EPINEPHRINE, DOPAMINE, PACING SECOND-LINE TREATMENT FOR SYMPTOMATIC BRADYCARDIA
ROSC! - Call List
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
CAUSES OF DYSRHYTHMIAS
CAD, ELECTROLYTE IMBALANCES, IMPAIRED GAS EXCHANGE, DRUG TOXICITY
SHOULD BE HELD 48 HOURS BEFORE CARDIOVERSION DUE TO RISK OF VENTRICULAR FIBRILLATION
DIGOXIN
TWO RHYTHMS THAT REQUIRE DEFIBRILLATION
PULSELESS VENTRICULAR TACHYCARDIA & VENTRICULAR FIBRILLATION
RECOMMENDED MEDICATIONS TO TREAT VENTRICULAR TACHYCARDIA WITH A PULSE
PROCAINAMIDE, SOTALOL, AMIODARONE
FIRST LINE TREATMENT FOR PULSELESS TACHYCARDIA AND VENTRICULAR FIBRILLATION
EPINEPHRINE
INFERIOR MYOCARDIAL INFARCTION
LEADS II, III, AND AVF
OFTEN THE RHYTHM THAT PRECEDES VENTRICULAR FIBRILLATION
PULSELESS VENTRICULAR TACHYCARDIA
NATURAL PACEMAKER OF THE HEART
SA NODE
REPRESENTS ATRIAL DEPOLARIZATION
P WAVE
RECOMMENDED TREATMENT FOR SUPRAVENTRICULAR TACHYCARDIA (SVT)
VAGAL MANEUVERS, ADENOSINE, BETA BLOCKERS, CALCIUM CHANNEL BLOCKERS
ANTERIOR MYOCARDIAL INFARCTION
LEADS V3 AND V4
TREATMENT RECOMMENDED FOR ANY FAST RHYTHM WITH SIGNS OF SHOCK OR POOR PERFUSION
SYNCHRONIZED CARDIOVERSION
RECOMMENDED TREATMENT FOR THIRD DEGREE HEART BLOCK
PERMANENT PACEMAKER
PROPERTIES OF CARDIAC CELLS
AUTOMATICITY, CONDUCTION, CONTRACTILITY, EXCITABILITY
1ST LINE TREATMENT FOR SYMPTOMATIC BRADYCARDIA
ATROPINE
EXAMINE FOR ELEVATION OR DEPRESSION TO EVALUATE FOR ISCHEMIA, INJURY, OR INFARCTION
ST SEGMENT
TWO MAIN COMPLICATIONS OF ATRIAL FIBRILLATION
CLOTTING EVENTS & HEART FAILURE
ITS PRESENCE OFTEN INDICATES AN ELECTROLYTE IMBALANCE, PARTICULARLY HYPOKALEMIA
U WAVE
NORMAL PR INTERVAL TIME
0.12 - .20 SECONDS
SECOND-LINE TREATMENT FOR PULSELESS VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION
AMIODARONE & LIDOCAINE
WHAT IS NORMAL CARDIAC OUTPUT
4-8 LITERS PER MINUTE
RECOMMENDED TREATMENT FOR TORSADES DE POINTES
MAGNESIUM
TWO MAIN NURSING DIAGNOSES RELATED TO DYSRHYTHMIAS
DECREASED CARDIAC OUTPUT, INEFFECTIVE TISSUE PERFUSION
SECOND-LINE TREATMENT FOR SYMPTOMATIC BRADYCARDIA
EPINEPHRINE, DOPAMINE, PACING